Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$11.7 - $14.98 $7,289 - $9,332
-623 Reduced 0.88%
69,873 $867,000
Q4 2023

Feb 13, 2024

SELL
$13.09 - $14.98 $7,422 - $8,493
-567 Reduced 0.8%
70,496 $985,000
Q3 2023

Nov 13, 2023

BUY
$12.64 - $14.99 $25,697 - $30,474
2,033 Added 2.95%
71,063 $1.05 Million
Q2 2023

Aug 04, 2023

BUY
$9.85 - $13.17 $37,695 - $50,401
3,827 Added 5.87%
69,030 $891,000
Q1 2023

May 12, 2023

BUY
$9.44 - $11.88 $2,813 - $3,540
298 Added 0.46%
65,203 $639,000
Q4 2022

Feb 10, 2023

BUY
$10.27 - $13.29 $1,365 - $1,767
133 Added 0.21%
64,905 $690,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $7,119 - $12,504
717 Added 1.12%
64,772 $676,000
Q2 2022

Aug 12, 2022

BUY
$7.45 - $12.83 $78,441 - $135,087
10,529 Added 19.67%
64,055 $806,000
Q1 2022

May 13, 2022

SELL
$9.75 - $14.44 $36,738 - $54,409
-3,768 Reduced 6.58%
53,526 $580,000
Q4 2021

Feb 11, 2022

SELL
$13.17 - $20.94 $22,573 - $35,891
-1,714 Reduced 2.9%
57,294 $806,000
Q3 2021

Nov 12, 2021

SELL
$9.16 - $19.83 $12,842 - $27,801
-1,402 Reduced 2.32%
59,008 $1.13 Million
Q2 2021

Aug 13, 2021

SELL
$7.25 - $10.99 $10,998 - $16,671
-1,517 Reduced 2.45%
60,410 $595,000
Q1 2021

May 07, 2021

BUY
$4.57 - $11.18 $749 - $1,833
164 Added 0.27%
61,927 $609,000
Q4 2020

Feb 12, 2021

SELL
$3.73 - $5.6 $6,609 - $9,923
-1,772 Reduced 2.79%
61,763 $275,000
Q3 2020

Nov 04, 2020

BUY
$4.32 - $11.7 $38,175 - $103,392
8,837 Added 16.16%
63,535 $275,000
Q2 2020

Aug 12, 2020

BUY
$2.94 - $9.1 $15,764 - $48,794
5,362 Added 10.87%
54,698 $485,000
Q1 2020

May 04, 2020

SELL
$2.27 - $6.2 $6,469 - $17,670
-2,850 Reduced 5.46%
49,336 $174,000
Q4 2019

Feb 05, 2020

SELL
$3.46 - $6.93 $1,522 - $3,049
-440 Reduced 0.84%
52,186 $299,000
Q3 2019

Nov 08, 2019

BUY
$2.69 - $4.85 $30,725 - $55,396
11,422 Added 27.72%
52,626 $188,000
Q2 2019

Aug 13, 2019

BUY
$3.65 - $7.89 $5,281 - $11,416
1,447 Added 3.64%
41,204 $164,000
Q1 2019

May 06, 2019

SELL
$7.08 - $12.09 $9,126 - $15,584
-1,289 Reduced 3.14%
39,757 $291,000
Q4 2018

Feb 13, 2019

SELL
$8.14 - $13.28 $2,564 - $4,183
-315 Reduced 0.76%
41,046 $376,000
Q3 2018

Nov 09, 2018

BUY
$11.85 - $16.0 $8,816 - $11,904
744 Added 1.83%
41,361 $513,000
Q2 2018

Aug 08, 2018

BUY
$15.15 - $20.75 $25,876 - $35,441
1,708 Added 4.39%
40,617 $619,000
Q1 2018

May 07, 2018

SELL
$14.65 - $19.9 $30,662 - $41,650
-2,093 Reduced 5.1%
38,909 $772,000
Q4 2017

Feb 09, 2018

BUY
$17.3 - $24.08 $10,431 - $14,520
603 Added 1.49%
41,002 $767,000
Q3 2017

Nov 09, 2017

BUY
$15.2 - $21.5 $614,064 - $868,578
40,399
40,399 $869,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.